Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs Lidocaine for Refractory Chronic Migraine
NCT06935552Phase 1Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jun 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of ketamine and Lidocaine Hydrochloride Injection, without epinephrine in chronic migraine (3 arms), sponsored by Assiut University. Primary endpoints: Numeric Rating Scale at 6 weeks and Migraine Disability Assessment at 6 weeks. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
ketamineLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT06935552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06935552.